Cover Image
市場調查報告書

美國的免疫化學市場

Analysis of the US Immunochemistry Market

出版商 Frost & Sullivan 商品編碼 316729
出版日期 內容資訊 英文 88 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的免疫化學市場 Analysis of the US Immunochemistry Market
出版日期: 2014年10月16日 內容資訊: 英文 88 Pages
簡介

本報告提供美國的免疫化學、臨床化學的市場相關調查、市場收益的變化與預測、主要供應商的分析儀分析對象物、價格、平均折扣幅度、安裝基礎的變化(模式)、市場上的課題、競爭環境與競爭因素、主要經營者的策略、未來展望等彙整資料。

第1章 摘要整理

第2章 調查手法

第3章 市場定義、概要

  • 市場定義
  • 市場概要
  • 市場課題
  • 各產品種類趨勢
  • 免疫化學化驗的潛在成長區域
  • 目前加入經營者的策略
  • 競爭因素
  • 現在及未來環境

第4章 收益預測:免疫化學市場

  • 收益預測:免疫化學市場
  • 收益預測:臨床化學市場
  • 收益相關討論

第5章 各製造商、模式安裝基礎分析:ROCHE DIAGNOSTICS

第6章 各製造商、模式安裝基礎分析:THERMO FISHER SCIENTIFIC

第7章 各製造商、模式安裝基礎分析:ABBOTT DIAGNOSTICS

第8章 各製造商、模式安裝基礎分析:TOSOH BIOSCIENCE

第9章 各製造商、模式安裝基礎分析:BECKMAN COULTER

第10章 各製造商、模式安裝基礎分析:SIEMENS HEALTHCARE DIAGNOSTICS

第11章 各製造商、模式安裝基礎分析:BIOMeRIEUX、DIASORIN

第12章 各製造商、模式安裝基礎分析:BIO-RAD、INOVA DIAGNOSTICS、IDS

第13章 各製造商、模式安裝基礎分析:ORTHO-CLINICAL DIAGNOSTICS, INC.

第14章 各製造商、模式安裝基礎分析:AWARENESS TECHNOLOGY、ALERE、THE BINDING SITE

第15章 客戶區分

  • 競爭經營者的覆蓋範圍比較分析

第16章 價格、折扣

第17章 策略性建議

第18章 總論

第19章 FROST 關於SULLIVAN

目錄
Product Code: NE6F-01-00-00-00

Clinicians Will Likely Opt for Integrated Analyzers over Standalone Clinical and Immunoassay Analyzers in the Next 2 Years

This study provides trends in the US immunochemistry market and the clinical chemistry market. The install base of analyzer models from top vendors are projected from 2012 and 2013, and resulting trends have been studied. The study includes list prices of analyzers, analytes detected, and average discounts offered. Customer segmentation includes various analyzers from vendors such as Abbott Diagnostics, Siemens Healthcare, Roche Diagnostics,

Phadia (Thermo Fisher Scientific), Alere, Inova Diagnostics, Tosoh Bioscience, bioMérieux, DiaSorin, Bio-Rad, IDS, Ortho-Clinical Diagnostics, Awareness Technology, The Binding Site, and Beckman Coulter.

Table of Contents

1 . EXECUTIVE SUMMARY

  • 1. Executive Summary-Key Findings
  • 2. Executive Summary-Key Findings (continued)
  • 3. Executive Summary-Key Findings (continued)
  • 4. Key Companies to Watch
  • 5. Key Companies to Watch (continued)

2 . METHODOLOGY

  • 1. Methodology
  • 2. Methodology (continued)

3 . MARKET DEFINITIONS AND OVERVIEW

  • 1. Market Definitions
  • 2. Market Definitions (continued)
  • 3. Market Definitions (continued)
  • 4. Market Overview
  • 5. Market Challenges
  • 6. Market Challenges (continued)
  • 7. Product Segment Trends
  • 8. Possible Areas of Growth for Immunochemistry Assays
  • 9. Current Market Participant Strategies
  • 10. Current Market Participant Strategies (continued)
  • 11. Competitive Factors
  • 12. Competitive Factors (continued)
  • 13. Current and Future Landscape
  • 14. Current and Future Landscape (continued)

4 . REVENUE FORECAST-IMMUNOCHEMISTRY MARKET

  • 1. Revenue Forecast-Immunochemistry Market
  • 2. Revenue Forecast-Immunochemistry Market (continued)
  • 3. Revenue Forecast-Clinical Chemistry Market
  • 4. Revenue Discussion

5 . INSTALL BASE ANALYSIS BY MANUFACTURER AND MODEL-ROCHE DIAGNOSTICS

  • 1. OEM-Roche Diagnostics
  • 2. OEM-Roche Diagnostics (continued)

6 . THERMO FISHER SCIENTIFIC

  • 1. OEM-Thermo Fisher Scientific
  • 2. OEM-Thermo Fisher Scientific (continued)

7 . ABBOTT DIAGNOSTICS

  • 1. OEM-Abbott Diagnostics
  • 2. OEM-Abbott Diagnostics (continued)

8 . TOSOH BIOSCIENCE

  • 1. OEM-Tosoh Bioscience
  • 2. OEM-Tosoh Bioscience (continued)

9 . BECKMAN COULTER

  • 1. OEM-Beckman Coulter
  • 2. OEM-Beckman Coulter (continued)

10 . SIEMENS HEALTHCARE DIAGNOSTICS

  • 1. OEM-Siemens Healthcare Diagnostics
  • 2. OEM-Siemens Healthcare Diagnostics (continued)
  • 3. OEM-Siemens Healthcare Diagnostics (continued)
  • 4. OEM-Siemens Healthcare Diagnostics (continued)

11 . BIOMéRIEUX AND DIASORIN

  • 1. OEM-bioMérieux and DiaSorin
  • 2. OEM-bioMérieux and DiaSorin (continued)
  • 3. OEM-bioMérieux and DiaSorin (continued)

12 . BIO-RAD, INOVA DIAGNOSTICS, AND IDS

  • 1. OEM-Bio-Rad, Inova Diagnostics, and Instant Diagnostic Systems (IDS)
  • 2. OEM-Bio-Rad, Inova Diagnostics, and IDS (continued)

13 . ORTHO-CLINICAL DIAGNOSTICS, INC.

  • 1. OEM-Ortho-Clinical Diagnostics
  • 2. OEM-Ortho-Clinical Diagnostics (continued)
  • 3. OEM-Ortho-Clinical Diagnostics (continued)

14 . AWARENESS TECHNOLOGY, ALERE, AND THE BINDING SITE

  • 1. OEMAwareness Technology, Alere, and The Binding Site
  • 2. OEMAwareness Technology, Alere, and The Binding Site (continued)

15 . CUSTOMER SEGMENT FOCUS

  • 1. Comparative Analysis of Competitor Coverage

16 . PRICING AND DISCOUNTS

  • 1. Pricing and Discounts
  • 2. Pricing and Discounts (continued)
  • 3. Pricing and Discounts (continued)

17 . STRATEGIC RECOMMENDATIONS

  • 1. Strategic Recommendations
  • 2. Strategic Recommendations (continued)
  • 3. Strategic Recommendations (continued)

18 . THE LAST WORD

  • 1. The Last Word
  • 2. Legal Disclaimer

19 . THE FROST & SULLIVAN STORY

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top